UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase‐by‐Phase Review of Migraine Pathophysiology

Headache, 2018-05, Vol.58 (S1), p.4-16

Dodick, David W.

2018

Volltextzugriff (PDF)

CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications

Cephalalgia, 2019-03, Vol.39 (3), p.445-458

Dodick, David W

2019

Volltextzugriff (PDF)

Migraine and risk of stroke

Journal of neurology, neurosurgery and psychiatry, 2020-06, Vol.91 (6), p.593-604

2020

Volltextzugriff (PDF)

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Cephalalgia, 2018-05, Vol.38 (6), p.1026-1037

2018

Volltextzugriff (PDF)

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Lancet neurology, 2016-04, Vol.15 (4), p.382-390

2016

Volltextzugriff (PDF)

Migraine

The Lancet (British edition), 2018-03, Vol.391 (10127), p.1315-1330

Dodick, David W

2018

Volltextzugriff (PDF)

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

Lancet neurology, 2014-09, Vol.13 (9), p.885-892

2014

Volltextzugriff (PDF)

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

The New England journal of medicine, 2019-07, Vol.381 (2), p.132-141

2019

Volltextzugriff (PDF)

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

Cephalalgia, 2016-08, Vol.36 (9), p.887-898

2016

Volltextzugriff (PDF)

Functional MRI of migraine

Lancet neurology, 2015, Vol.14 (1), p.81-91

2015

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Lancet neurology, 2015-11, Vol.14 (11), p.1081-1090

2015

Volltextzugriff (PDF)

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

Cephalalgia, 2021-03, Vol.41 (3), p.340-352

2021

Volltextzugriff (PDF)

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Lancet neurology, 2014-11, Vol.13 (11), p.1100-1107

2014

Volltextzugriff (PDF)

Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

Journal of headache and pain, 2020-03, Vol.21 (1), p.23-23, Article 23

2020

Volltextzugriff (PDF)

Tau Positron-Emission Tomography in Former National Football League Players

The New England journal of medicine, 2019-05, Vol.380 (18), p.1716-1725

2019

Volltextzugriff (PDF)

Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks

Cephalalgia, 2023-02, Vol.43 (2), p.3331024221137092-3331024221137092

2023

Volltextzugriff (PDF)

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

Cephalalgia, 2011-02, Vol.31 (3), p.271-285

2011

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Headache, 2010-06, Vol.50 (6), p.921-936

2010

Volltextzugriff (PDF)

Disability, quality of life, productivity impairment and employer costs of migraine in the workplace

Journal of headache and pain, 2021-04, Vol.22 (1), p.29-29, Article 29

2021

Volltextzugriff (PDF)

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

The Lancet (British edition), 2008-12, Vol.372 (9656), p.2115-2123

2008

Volltextzugriff (PDF)

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

Mayo Clinic proceedings, 2016-05, Vol.91 (5), p.596-611

2016

Volltextzugriff (PDF)

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study

Journal of headache and pain, 2018-05, Vol.19 (1), p.38-9, Article 38

2018

Volltextzugriff (PDF)

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies

Headache, 2020-02, Vol.60 (2), p.348-359

2020

Volltextzugriff (PDF)

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Lancet neurology, 2010-04, Vol.9 (4), p.373-380

2010

Volltextzugriff (PDF)

Late-life migraine accompaniments: A narrative review

Cephalalgia, 2015-09, Vol.35 (10), p.894-911

2015

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

Englisch
(558)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Headache
(135)
Cephalalgia
(85)
Neurology
(52)
Lancet Neurology
(24)
Mayo Clinic Proceedings
(20)
Headache: The Journal Of Head And Face Pain
(14)
Journal Of Headache And Pain
(12)
The New England Journal Of Medicine
(12)
Current Pain And Headache Reports
(10)
The journal Of Headache And Pain
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A Phase‐by‐Phase Review of Migraine Pathophysiology

CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications

Migraine and risk of stroke

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Migraine

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

Functional MRI of migraine

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

Tau Positron-Emission Tomography in Former National Football League Players

Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Disability, quality of life, productivity impairment and employer costs of migraine in the workplace

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Late-life migraine accompaniments: A narrative review

Suchergebnisse filtern